DEGO / USDT

ZKC / USDT

ZKC / USDC

ZKC / TRY

ZKC / FDUSD

ZKC / BNB

BAT / BTC

DUSK / BTC

ARPA / BTC

BB / BTC

OPEN / BNB

C / FDUSD

AI / BNB

D / TRY

FUN / USDC

D / USDT

RESOLV / FDUSD

FUN / USDT

PROVE / TRY

TUT / USDT

RUBICON RESEARCH LIMITED

SAMBHAAV MEDIA LTD

GLOBAL VEC HELICORP LTD

SHARE IND. SECURITIES LTD

MASK INVESTMENTS LIMITED

HYBRID FINANCIAL SERVICE

GUJARAT RAFFIA INDUST LTD

ELECTRO FORCE (INDIA) LTD

NELCAST LIMITED

BLS INTL SERVS LTD

KORE DIGITAL LIMITED

UNILEX COLOURS AND CHEM L

MASTER TRUST LIMITED

GURUNANAK AGRICULTUR IN L

3I INFOTECH LTD

EDELAMC - ESILVER

GROWWAMC - GROWWSLVR

PARAMATRIX TECHNOLOGIES L

MOTILALAMC - MOSILVER

G M BREWERIES LTD

Click here to get full coverage on Lyka Labs Updates on Amalgamation Process - TipRanks

Lyka Labs Updates on Amalgamation Process  TipRanks

Lyka Labs Updates on Amalgamation Process - TipRanks

Click here to get full coverage on Lyka Labs' Amalgamation Case: Income Tax Department Granted 15-Day Extension for Reply - scanx.trade

Lyka Labs' Amalgamation Case: Income Tax Department Granted 15-Day Extension for Reply  scanx.trade

Lyka Labs' Amalgamation Case: Income Tax Department Granted 15-Day Extension for Reply - scanx.trade

Click here to get full coverage on What Technical Resistance Could Cap Lyka Labs Limiteds Upside - Dividend Stability Analysis & High-Risk, High-Reward? We Find the Winners - earlytimes.in

What Technical Resistance Could Cap Lyka Labs Limiteds Upside - Dividend Stability Analysis & High-Risk, High-Reward? We Find the Winners  earlytimes.in

What Technical Resistance Could Cap Lyka Labs Limiteds Upside - Dividend Stability Analysis & High-Risk, High-Reward? We Find the Winners - earlytimes.in

Click here to get full coverage on Lyka Labs Hits New 52-Week Low at Rs 115.00 Amid Market Struggles - Markets Mojo

Lyka Labs Hits New 52-Week Low at Rs 115.00 Amid Market Struggles  Markets Mojo

Lyka Labs Hits New 52-Week Low at Rs 115.00 Amid Market Struggles - Markets Mojo

Click here to get full coverage on Lyka Labs secures Indian patent for Pregabalin Gel 8% - Indian Pharma Post

Lyka Labs secures Indian patent for Pregabalin Gel 8%  Indian Pharma Post

Lyka Labs secures Indian patent for Pregabalin Gel 8% - Indian Pharma Post

Click here to get full coverage on Lyka Labs gets Indian Patent for diabetic neuropathic pain management gel Pregabalin - Medical Dialogues

Lyka Labs gets Indian Patent for diabetic neuropathic pain management gel Pregabalin  Medical Dialogues

Lyka Labs gets Indian Patent for diabetic neuropathic pain management gel Pregabalin - Medical Dialogues

Click here to get full coverage on Will New Partnerships Boost Lyka Labs Limiteds Outlook - Bear Market Strategies & High Yield Portfolio Picks - earlytimes.in

Will New Partnerships Boost Lyka Labs Limiteds Outlook - Bear Market Strategies & High Yield Portfolio Picks  earlytimes.in

Will New Partnerships Boost Lyka Labs Limiteds Outlook - Bear Market Strategies & High Yield Portfolio Picks - earlytimes.in

Click here to get full coverage on Our Take On Lyka Labs Limited’s (NSE:LYKALABS) CEO Salary - Yahoo Finance

Our Take On Lyka Labs Limited’s (NSE:LYKALABS) CEO Salary  Yahoo Finance

Our Take On Lyka Labs Limited’s (NSE:LYKALABS) CEO Salary - Yahoo Finance

Click here to get full coverage on NCLT Reserves Order on Lyka Labs-Lyka Exports Merger, Signals No Objection - scanx.trade

NCLT Reserves Order on Lyka Labs-Lyka Exports Merger, Signals No Objection  scanx.trade

NCLT Reserves Order on Lyka Labs-Lyka Exports Merger, Signals No Objection - scanx.trade

Click here to get full coverage on Lyka Labs Hits New 52-Week Low, Trading at Rs 95.3 - Markets Mojo

Lyka Labs Hits New 52-Week Low, Trading at Rs 95.3  Markets Mojo

Lyka Labs Hits New 52-Week Low, Trading at Rs 95.3 - Markets Mojo

Click here to get full coverage on Buy or sell: Ganesh Dongre of Anand Rathi recommends three stocks to buy on Monday - 6 January - Mint

Buy or sell: Ganesh Dongre of Anand Rathi recommends three stocks to buy on Monday - 6 January  Mint

Buy or sell: Ganesh Dongre of Anand Rathi recommends three stocks to buy on Monday - 6 January - Mint

Click here to get full coverage on Q4 Results Highlights 26 May: Snowman Logistics Q4 profit up, Sundaram Finance Q4 profit at ₹553 cr, Rategain Q4 profit at ₹55 cr, GIC, Sumitomo, KEC International, Brainbees, Blue Dart, Akums Drugs, Lyka Labs to announce Q4 results today, Gillette shar - BusinessLine

Q4 Results Highlights 26 May: Snowman Logistics Q4 profit up, Sundaram Finance Q4 profit at ₹553 cr, Rategain Q4 profit at ₹55 cr, GIC, Sumitomo, KEC International, Brainbees, Blue Dart, Akums Drugs, Lyka Labs to announce Q4 results today, Gillette shar  BusinessLine

Q4 Results Highlights 26 May: Snowman Logistics Q4 profit up, Sundaram Finance Q4 profit at ₹553 cr, Rategain Q4 profit at ₹55 cr, GIC, Sumitomo, KEC International, Brainbees, Blue Dart, Akums Drugs, Lyka Labs to announce Q4 results today, Gillette shar - BusinessLine

Click here to get full coverage on Lyka Labs' Amalgamation with Lyka Exports Faces Delay as NCLT Seeks Income Tax Report - scanx.trade

Lyka Labs' Amalgamation with Lyka Exports Faces Delay as NCLT Seeks Income Tax Report  scanx.trade

Lyka Labs' Amalgamation with Lyka Exports Faces Delay as NCLT Seeks Income Tax Report - scanx.trade

Click here to get full coverage on Lyka Labs Hits 52-Week Low, Trading at Rs 90.2 - Markets Mojo

Lyka Labs Hits 52-Week Low, Trading at Rs 90.2  Markets Mojo

Lyka Labs Hits 52-Week Low, Trading at Rs 90.2 - Markets Mojo

Click here to get full coverage on Lyka Labs to Consider Preference Share Redemption and Company Secretary Appointment in Upcoming Board Meeting - scanx.trade

Lyka Labs to Consider Preference Share Redemption and Company Secretary Appointment in Upcoming Board Meeting  scanx.trade

Lyka Labs to Consider Preference Share Redemption and Company Secretary Appointment in Upcoming Board Meeting - scanx.trade

Click here to get full coverage on Lyka Labs Q2FY22 consolidated PAT at Rs. 28.43Cr - Indian Pharma Post

Lyka Labs Q2FY22 consolidated PAT at Rs. 28.43Cr  Indian Pharma Post

Lyka Labs Q2FY22 consolidated PAT at Rs. 28.43Cr - Indian Pharma Post

Click here to get full coverage on Lyka Labs Reports Mixed Financial Results Amidst Significant Profit Growth and Operational Challenges - Markets Mojo

Lyka Labs Reports Mixed Financial Results Amidst Significant Profit Growth and Operational Challenges  Markets Mojo

Lyka Labs Reports Mixed Financial Results Amidst Significant Profit Growth and Operational Challenges - Markets Mojo

Click here to get full coverage on Lyka Labs Reports Strong Financial Growth, Signaling Positive Trends in Pharmaceuticals Sector - Markets Mojo

Lyka Labs Reports Strong Financial Growth, Signaling Positive Trends in Pharmaceuticals Sector  Markets Mojo

Lyka Labs Reports Strong Financial Growth, Signaling Positive Trends in Pharmaceuticals Sector - Markets Mojo

Click here to get full coverage on Lyka Labs Faces Significant Stock Volatility Amidst Underperformance in Pharmaceuticals Sector - Markets Mojo

Lyka Labs Faces Significant Stock Volatility Amidst Underperformance in Pharmaceuticals Sector  Markets Mojo

Lyka Labs Faces Significant Stock Volatility Amidst Underperformance in Pharmaceuticals Sector - Markets Mojo

Click here to get full coverage on Lyka Labs acquisition by Ipca Laboratories could open strong growth opportunities - Moneycontrol

Lyka Labs acquisition by Ipca Laboratories could open strong growth opportunities  Moneycontrol

Lyka Labs acquisition by Ipca Laboratories could open strong growth opportunities - Moneycontrol

Click here to get full coverage on Lyka Labs shares rally 7% on CDSCO nod for diabetic neuropathy pain drug | News on Markets - Business Standard

Lyka Labs shares rally 7% on CDSCO nod for diabetic neuropathy pain drug | News on Markets  Business Standard

Lyka Labs shares rally 7% on CDSCO nod for diabetic neuropathy pain drug | News on Markets - Business Standard

Click here to get full coverage on Ipca Labs approves acquisition of 26.5% stake in Lyka Labs - Mint

Ipca Labs approves acquisition of 26.5% stake in Lyka Labs  Mint

Ipca Labs approves acquisition of 26.5% stake in Lyka Labs - Mint

Click here to get full coverage on ​Diwali picks: Top 5 stocks with up to 105% upside potential in Samvat 2081 - The Economic Times

​Diwali picks: Top 5 stocks with up to 105% upside potential in Samvat 2081  The Economic Times

​Diwali picks: Top 5 stocks with up to 105% upside potential in Samvat 2081 - The Economic Times

Click here to get full coverage on Ipca Laboratories acquires 26 % stake in Lyka Labs, makes open offer - Indian Pharma Post

Ipca Laboratories acquires 26 % stake in Lyka Labs, makes open offer  Indian Pharma Post

Ipca Laboratories acquires 26 % stake in Lyka Labs, makes open offer - Indian Pharma Post

Click here to get full coverage on Ipca Laboratories hikes stake in Lyka Labs - Business Standard

Ipca Laboratories hikes stake in Lyka Labs  Business Standard

Ipca Laboratories hikes stake in Lyka Labs - Business Standard

Click here to get full coverage on Lyka Labs Shares Soar 7% on CDSCO Approval for Drug - Equitypandit

Lyka Labs Shares Soar 7% on CDSCO Approval for Drug  Equitypandit

Lyka Labs Shares Soar 7% on CDSCO Approval for Drug - Equitypandit

Click here to get full coverage on Promoters of Lyka Labs settle case with Sebi; pays Rs 3.07 lakh as settlements charges - ETLegalWorld.com

Promoters of Lyka Labs settle case with Sebi; pays Rs 3.07 lakh as settlements charges  ETLegalWorld.com

Promoters of Lyka Labs settle case with Sebi; pays Rs 3.07 lakh as settlements charges - ETLegalWorld.com

Click here to get full coverage on Lyka Labs' Stock Reaches 52-Week High, Outperforms Sector with Positive Trend - Markets Mojo

Lyka Labs' Stock Reaches 52-Week High, Outperforms Sector with Positive Trend  Markets Mojo

Lyka Labs' Stock Reaches 52-Week High, Outperforms Sector with Positive Trend - Markets Mojo

Click here to get full coverage on IPCA Labs board OKs acquisition of over 26% stake in Lyka Labs; triggers open offer - Business Standard

IPCA Labs board OKs acquisition of over 26% stake in Lyka Labs; triggers open offer  Business Standard

IPCA Labs board OKs acquisition of over 26% stake in Lyka Labs; triggers open offer - Business Standard

Click here to get full coverage on Time-Barred CENVAT Credit Demands do not Attract Interest: CESTAT modifies Lyka Labs' Decision [Read Order] - Taxscan

Time-Barred CENVAT Credit Demands do not Attract Interest: CESTAT modifies Lyka Labs' Decision [Read Order]  Taxscan

Time-Barred CENVAT Credit Demands do not Attract Interest: CESTAT modifies Lyka Labs' Decision [Read Order] - Taxscan

Click here to get full coverage on SEBI bans Lyka Labs for 3 years for manipulating GDR to raise Rs 37 crore - Medical Dialogues

SEBI bans Lyka Labs for 3 years for manipulating GDR to raise Rs 37 crore  Medical Dialogues

SEBI bans Lyka Labs for 3 years for manipulating GDR to raise Rs 37 crore - Medical Dialogues

Click here to get full coverage on IPCA Labs To Buy More Than 26% Stake In Lyka Labs; Shares Jump - NDTV Profit

IPCA Labs To Buy More Than 26% Stake In Lyka Labs; Shares Jump  NDTV Profit

IPCA Labs To Buy More Than 26% Stake In Lyka Labs; Shares Jump - NDTV Profit

Click here to get full coverage on Ipca Labs Approves Acquisition of 26.5% Stake in Lyka Labs - Equitypandit

Ipca Labs Approves Acquisition of 26.5% Stake in Lyka Labs  Equitypandit

Ipca Labs Approves Acquisition of 26.5% Stake in Lyka Labs - Equitypandit

Click here to get full coverage on Lyka Labs inks out-licensing deal with US-based generics firm - Business Standard

Lyka Labs inks out-licensing deal with US-based generics firm  Business Standard

Lyka Labs inks out-licensing deal with US-based generics firm - Business Standard

Click here to get full coverage on Lyka Labs hits 5% upper circuit after Ipca buys 1 mn shares via bulk deals - Business Standard

Lyka Labs hits 5% upper circuit after Ipca buys 1 mn shares via bulk deals  Business Standard

Lyka Labs hits 5% upper circuit after Ipca buys 1 mn shares via bulk deals - Business Standard

Click here to get full coverage on Clearwater Capital Partners trims stake in Lyka Labs - BusinessLine

Clearwater Capital Partners trims stake in Lyka Labs  BusinessLine

Clearwater Capital Partners trims stake in Lyka Labs - BusinessLine

Click here to get full coverage on IPCA Laboratories Ltd to acquire majority stake in Lyka Labs Ltd - EquityBulls

IPCA Laboratories Ltd to acquire majority stake in Lyka Labs Ltd  EquityBulls

IPCA Laboratories Ltd to acquire majority stake in Lyka Labs Ltd - EquityBulls

Click here to get full coverage on Lyka Labs sells Tarapur manufacturing unit for Rs 38.6 crore - The Economic Times

Lyka Labs sells Tarapur manufacturing unit for Rs 38.6 crore  The Economic Times

Lyka Labs sells Tarapur manufacturing unit for Rs 38.6 crore - The Economic Times

Click here to get full coverage on Lyka Labs shares hit new 52-week high after Ipca Laboratories acquires 48 lakh shares of the company - Zee Business

Lyka Labs shares hit new 52-week high after Ipca Laboratories acquires 48 lakh shares of the company  Zee Business

Lyka Labs shares hit new 52-week high after Ipca Laboratories acquires 48 lakh shares of the company - Zee Business

Click here to get full coverage on Share market update: Lyka Labs, Lloyds Steels among top losers on BSE - The Economic Times

Share market update: Lyka Labs, Lloyds Steels among top losers on BSE  The Economic Times

Share market update: Lyka Labs, Lloyds Steels among top losers on BSE - The Economic Times

Click here to get full coverage on Hetero buys Lyka JV pie - Business Standard

Hetero buys Lyka JV pie  Business Standard

Hetero buys Lyka JV pie - Business Standard

Click here to get full coverage on Sequent Scientific buys Lyka's animal business - Business Standard

Sequent Scientific buys Lyka's animal business  Business Standard

Sequent Scientific buys Lyka's animal business - Business Standard

Click here to get full coverage on Lyka Labs shares fall 3% as Q1 net profit falls 20% YoY; Check earnings - Business Upturn

Lyka Labs shares fall 3% as Q1 net profit falls 20% YoY; Check earnings  Business Upturn

Lyka Labs shares fall 3% as Q1 net profit falls 20% YoY; Check earnings - Business Upturn

Click here to get full coverage on Lyka Labs receives CDSCO approval to manufacture and market Pregabalin Gel 8% w/w in India - Business Upturn

Lyka Labs receives CDSCO approval to manufacture and market Pregabalin Gel 8% w/w in India  Business Upturn

LYKALABS

Price Chart

Key Statistics

Technicals

About LYKALABS

Latest News

Lyka Labs Updates on Amalgamation Process - TipRanks

Lyka Labs' Amalgamation Case: Income Tax Department Granted 15-Day Extension for Reply - scanx.trade

What Technical Resistance Could Cap Lyka Labs Limiteds Upside - Dividend Stability Analysis & High-Risk, High-Reward? We Find the Winners - earlytimes.in

Advanced Charts

Top Gainers

Top Losers